when patents keep coming in one after the other. NCE will eventually be granted, and most likely, will be in the December OB. Vascepa is going to be a blockbuster, whether AMRN goes it alone or is bought out sooner or later. Either way, serious money will be made.
your statement that it will be granted is a guess at best. surest way I know of to lose money.
it is obviously a legal battle at this point. what you need to understand is that BP is having nothing to do with an offer to AMRN unless NCE is resolved. This is a trading stock for the next 30 days. No buy out, no NCE decision for 30 days. And guess where 30 days puts us------effectively, Q1 2013.
go review the CC where Joe Z says no answer is the worse possible outcome.
i.e. I cannot sell this company without the resolution of this issue.
But the fact is that it does affect pps in short term.
What I find really disgusting, is FDA. A thing like NCE is yes or no. Black or white. No other options.
After months of delay, now those genius leaks the info (well, CEO eventually said it) that FDA is going to release a draft letter.... he said it's that letter is going around since days/week.
What does this tell us?
That FDA has become a croupier. Or worse, a player in stockmarket.
FDA should be supposed to talk only by official channel and official press release.
This is like "place your bet, Sirs..... red or black?".
The FDA has a less than steller reputation and has had preasure
for a long time to "do the right thing" which they haven't in alot of cases.
They continue to shoot themselves in the foot.
Eventually they will get it right. jmo
Me too. Back before FDA approval of Vascepa, I expected approval and I thought the NCE would be out and the Company sold by late September.
So I have plans for this money I have still tied up. I guess a few months off isn't so bad. I've been trapped for years in a stock.
Let's just hope the conclusion ends up being what we hoped for and that we only lose a quarter or two of time.
I still have very positive feelings about this investment.